Skip to main content

Vasorin, an antagonist of TGF-β is decreased in glaucoma patients

Publication ,  Conference
Choi, JA; Karnam, S; Skiba, N; Maddala, R; Challa, P; Vann, R; Rao, V
Published in: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
2021

Duke Scholars

Published In

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

EISSN

1552-5783

ISSN

0146-0404

Publication Date

2021

Volume

62

Issue

8

Related Subject Headings

  • Ophthalmology & Optometry
  • 3212 Ophthalmology and optometry
  • 11 Medical and Health Sciences
  • 06 Biological Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Choi, J. A., Karnam, S., Skiba, N., Maddala, R., Challa, P., Vann, R., & Rao, V. (2021). Vasorin, an antagonist of TGF-β is decreased in glaucoma patients. In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (Vol. 62).
Choi, Jin A., Shruthi Karnam, Nikolai Skiba, Rupalatha Maddala, Pratap Challa, Robin Vann, and Vasantha Rao. “Vasorin, an antagonist of TGF-β is decreased in glaucoma patients.” In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Vol. 62, 2021.
Choi JA, Karnam S, Skiba N, Maddala R, Challa P, Vann R, et al. Vasorin, an antagonist of TGF-β is decreased in glaucoma patients. In: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2021.
Choi, Jin A., et al. “Vasorin, an antagonist of TGF-β is decreased in glaucoma patients.” INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 62, no. 8, 2021.
Choi JA, Karnam S, Skiba N, Maddala R, Challa P, Vann R, Rao V. Vasorin, an antagonist of TGF-β is decreased in glaucoma patients. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2021.

Published In

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

EISSN

1552-5783

ISSN

0146-0404

Publication Date

2021

Volume

62

Issue

8

Related Subject Headings

  • Ophthalmology & Optometry
  • 3212 Ophthalmology and optometry
  • 11 Medical and Health Sciences
  • 06 Biological Sciences